Xcout Intel
Pathos AI, Inc.Unicorn · $1–2B
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Subscribe to see Pathos AI, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pathos AI, Inc. at a glance
Pathos AI, Inc. is a biotech company headquartered in United States. Its most recent funding round, Series D, raised $365M in May 2025. Xcout tracks 33 named people at Pathos AI, Inc., including Iker Huerga (CEO). Xcout recorded 6 job postings from Pathos AI, Inc. in the last 90 days.
Pathos AI, Inc. leadership
- Iker HuergaCEO
- Ryan FukushimaChief Executive Officer
- Matt De SilvaCHIEF OPERATING OFFICER
- Eric SchadtCHIEF SCIENCE OFFICER
- Mark FereshtehChief Scientific Officer
- Steve KyeChief Development lead
27 more named people on record for Pathos AI, Inc., with roles, board committees and tenure — see the full roster →
Pathos AI, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $365M | — | |
| SEC Form D filing | $62M | — | |
| Series C | $62M | 1 named | |
| SEC Form D filing | $20M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Pathos AI, Inc.
Xcout recorded 6 job postings from Pathos AI, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Pathos AI, Inc.'s hiring signals →
Pathos AI, Inc. competitors
A few of Pathos AI, Inc.'s closest competitors — see the full list of competitors and alternatives →
Cartography Biosciences is a biotechnology company that uses single-cell genomics, proteomics, machine learning, and computational biology to analyze massive datasets of healthy and cancerous human cells. Through its platforms, the company identifies new therapeutic targets and develops precision molecules designed to target tumors while sparing healthy tissue.
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
ArrePath is a biotechnology research company based in Princeton, New Jersey, focusing on AI-enabled oral small-molecule discovery. The company uses proprietary artificial intelligence and machine learning workflows proven in antibacterial discovery.
Conquest Labs builds artificial intelligence models designed to engineer hyperpolypharmacy-driven therapies. The company's technology aims to guide biological systems from diseased to healthy states, focusing initially on developing treatments for cancer.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
Insitro is a physical artificial intelligence company headquartered in South San Francisco, California, that uses machine learning and data at scale to build a different kind of drug company.
Get Pathos AI, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Pathos AI, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Pathos AI, Inc. in Xcout Intel
- 33 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access